DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

MannKind Corp (NASDAQ: MNKD)

5.24 0.13 (2.54%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MNKD $5.24 2.54%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.17
Previous Close $5.11
Daily Range $5.15 - $5.30
52-Week Range $3.80 - $11.48
Market Cap $2.1B
P/E Ratio -10.02
Dividend (Yield) $0.00 (0.0%)
Volume 3,275,001
Average Daily Volume 5,488,434
Current FY EPS -$0.34

Sector

Healthcare

Industry

Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary

Investors' Love/Hate Relationship with MannKind Corp. Stock

Emotions run high when it comes to this biotech.

MannKind Stock Approaching Pre-FDA Approval Price: Is A Bottom Coming?

Major Biotech Is So-So for Short Sellers

Analyst: MannKind Afrezza Estimates Are Being Changed 'Based On Physician Feedback'

Early Adopters Embrace Afrezza, As New Inhaled Insulin Enters Market

Did Researchers Just Unlock a Type 1 Diabetes Cure?

Forget just trying to treat the symptoms of type 1 diabetes! According to the findings from this latest study, a type 1 diabetes cure may be possible.

Confessions of a Value Investor Stuck in a High-Growth Industry

It's OK to buy premium-priced biotechs.

Benzinga's Top #PreMarket Losers

Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press

Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press Releases

MannKind's Financial Health Complicated by Looming $100M Debt Payment

See More MNKD News...

MNKD's Top Competitors

MNKD $5.24 (2.54%)
Current stock: MNKD
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB